Severe bleeding in two patients due to increased sensitivity of factor IX activity to phenprocoumon therapy

Annals of Hematology

Volumn 74, Issue 6, 1997, Pages 265-268

  Quenzel, E M ^a   Hertfelder, H J ^a   Oldenburg, J ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bleeding; Factor IX; Oral anticoagulant therapy; Phenprocoumon

Indexed keywords

ANTICOAGULANT AGENT; BATROXOBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; PHENPROCOUMON; PROTHROMBIN; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; CASE REPORT; HUMAN; MALE; OPEN HEART SURGERY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADULT; AGED; ANTICOAGULANTS; FACTOR IX; HEMORRHAGE; HUMANS; MALE; PHENPROCOUMON; POSTOPERATIVE HEMORRHAGE;

EID: 0030833633     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050297     Document Type: Article

References (14)

1. Biggs R, Denson KWE (1963) The fate of prothrombin and factors VII, IX and X transfused to patients deficient in these factors. Br J Haematol 9 : 532-547
2. Born GVR, Cross MJ (1963) The aggregation of blood platelets. J Physiol 168 : 178-195
3. Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17 : 237-246
4. Hirsh J (1991) Oral anticoagulant drugs. N Engl J Med 324 : 1865-1875
5. Hoffman GC, Hewlett JS (1965) Exchange transfusion in hereditary factor VII (proconvertin) deficiency. Am J Clin Pathol 44 : 198-202
6. Hull R, Hirsh J, Jay R, et al (1982) Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 307 : 1676-1681
7. Kumar S, Haigh JRM, Tate G, Boothby M, Joanes DN, Davies JA, Roberts BE, Feely MP (1990) Effect of warfarin on plasma concentrations of vitamin K-dependent coagulation factors in patients with stable control and monitored compliance. Br J Haematol 74 : 82-85
8. Loelieger EA, Hensen A (1961) Substitution therapy in haemophilia B. Thromb Diathes Haemorrh 6 : 391-410
9. Mielke HC (1984) International committee communications: measurement of the bleeding time. Thromb Haemost 52 : 210-211
10. Poller L, Taberner DA (1982) Dosage and control of oral anticoagulants: an international collaborative survey. Br J Haematol 51 : 479-485
11. Roberts HR, Lechler E, Webster WP, Penick GD (1965) Survival of transfused factor X in patients with Stuart disease. Thromb Diathes Haemorrh 13 : 305-313
12. Saour JN, Sieck JO, Mamo LAR, Gallus AS (1990) Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 322 : 428-432
13. Weiss P, Soff GA, Molkin H, Seligsohn U (1 987) Decline of proteins C and S and factor II, VII, IX and X during the initiation of warfarin therapy. Thromb Res 45 : 783-790
14. WHO Expert Committee on Biological Standardisation (1983) 31st Report. WHO Tech Rep Ser 687:81-105